J&J aims to 'save legs, change lives' with new peripheral artery disease awareness effort

Peripheral artery disease, or PAD, is a leading cause of amputations in the U.S. | Peripheral artery disease, or PAD, is a leading cause of amputations in the U.S. But the disease can be silent, so millions of Americans—especially Black Americans—don’t know they have it until it’s too late. Johnson & Johnson’s Janssen unit is hoping to change that with a new awareness initiative.

Jon Bloom, M.D. on LinkedIn: Video Severed: Diabetes Denial and

Kenneth Todd Moore on LinkedIn: J&J aims to 'save legs, change

About Us Save Legs. Change Lives™

About Us Save Legs. Change Lives™

Wilson Wound Healing Center Raises Awareness of Peripheral Artery

UConn's Vascular Surgeons Take DETOUR to Save Woman's Toes, Foot

New Janssen initiative aims to advance equitable care and address

Saving legs, changing lives – Revon Media

Peripheral Artery Disease National Action Plan

Editor's Choice -- European Society for Vascular Surgery (ESVS

The Janssen Pharmaceutical Companies of Johnson & Johnson on

Save Legs. Change Lives.™ Brings PAD Amputation Awareness Back to ACC

Peripheral Matters Peripheral Artery Disease: Moving From

Deborah Epps, PharmD on LinkedIn: J&J Covid-19 Vaccine Authorized

Peripheral Arterial Disease (PAD) Awareness Month